Old Web
English
Sign In
Acemap
>
authorDetail
>
E. M. Mahlis
E. M. Mahlis
Merck & Co.
Physical therapy
Medicine
Diabetes mellitus
Internal medicine
Endocrinology
3
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24‐month results from FACTS‐International
2008
International Journal of Clinical Practice
David M. Reid
David J. Hosking
David L. Kendler
Maria Luisa Brandi
John D. Wark
João Francisco Marques-Neto
G. Weryha
Nadia Verbruggen
Carolyn M. Hustad
E. M. Mahlis
Mary E. Melton
Show All
Source
Cite
Save
Citations (39)
More patients gain BMD with alendronate than risedronate after 24 months: Results of FOSAMAX (R) ACTONEL (R) comparison trials (FACTs) - International.
2006
Journal of Bone and Mineral Research
David L. Kendler
D.M. Reid
David J. Hosking
Ml Brandi
John D. Wark
João Francisco Marques-Neto
G. Weryha
N. Verbruggen
Carolyn M. Hustad
E. M. Mahlis
Mary E. Melton
Show All
Source
Cite
Save
Citations (0)
GREATER GAINS IN BMD WITH ALENDRONATE THAN RISEDRONATE AFTER 24 MONTHS: RESULTS OF FOSAMAX?? ACTONEL?? COMPARISON TRIALS (FACTS) - INTERNATIONAL: 86
2006
Jcr-journal of Clinical Rheumatology
Jo o F. Marques-Neto
David M. Reid
David J. Hosking
David L. Kendler
Maria Luisa Brandi
John D. Wark
G. Weryha
Nadia Verbruggen
Carolyn M. Hustad
E. M. Mahlis
Mary E. Melton
Show All
Source
Cite
Save
Citations (0)
1